BioInvent International AB (publ) (BOVNF)
USD 4.7
(0.0%)
USD 4.7
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -312.7 Million SEK | -920.63% |
| 2022 | -27.12 Million USD | 88.22% |
| 2021 | -29.04 Million USD | -271.51% |
| 2020 | -7.79 Million USD | 44.24% |
| 2019 | -14.01 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | -9.05 Million USD | 28.67% |
| 2024 Q1 | -7.94 Million SEK | 8.0% |
| 2024 Q2 | -154.48 Million SEK | -68.74% |
| 2023 Q1 | -7.36 Million USD | -2.04% |
| 2023 Q4 | -10.54 Million USD | -50.25% |
| 2023 FY | - USD | -920.63% |
| 2023 Q3 | -7.01 Million USD | 18.43% |
| 2023 Q2 | -8.6 Million USD | -16.88% |
| 2022 Q2 | 16.67 Million USD | 0.0% |
| 2022 FY | - USD | 88.22% |
| 2022 Q4 | -7.21 Million USD | -20.88% |
| 2022 Q3 | -5.96 Million USD | -135.8% |
| 2021 FY | - USD | -271.51% |
| 2020 FY | - USD | 44.24% |
| 2019 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | -340.209% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | -5174.276% |
| SQZ Biotechnologies Company | -64.14 Million USD | -387.531% |
| Evofem Biosciences, Inc. | -17.37 Million USD | -1700.271% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 432.532% |
| Mesoblast Limited | -62.38 Million USD | -401.215% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -20257.879% |
| Genus plc | 73.7 Million USD | 524.297% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | -4629.731% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | -8716.103% |
| Marizyme, Inc. | -34.28 Million USD | -812.175% |
| ContraFect Corporation | -64.99 Million USD | -381.095% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | -3464.831% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | -6808.827% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -22207.406% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | -11725.039% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | -13356.593% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | -60262.786% |
| Accustem Sciences Inc. | -3.74 Million USD | -8246.824% |
| RVL Pharmaceuticals plc | -48.22 Million USD | -548.406% |
| EV Biologics, Inc. | -1.26 Million USD | -24578.329% |
| Q BioMed Inc. | -617.62 Thousand USD | -50530.315% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | 8854.395% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -49347.191% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | -13588.269% |
| Biomind Labs Inc. | -1.03 Million USD | -30126.408% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | 9.87 Million USD | 3266.012% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | -4266.639% |
| Skye Bioscience, Inc. | -13.54 Million USD | -2208.218% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | -20923.563% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | -1250728.0% |
| Arch Therapeutics, Inc. | -3.88 Million USD | -7950.495% |
| IMV Inc. | -35.52 Million USD | -780.285% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | -1870.461% |
| Curative Biotechnology, Inc. | -2.5 Million USD | -12398.471% |
| GB Sciences, Inc. | -1.41 Million USD | -21923.403% |
| Alpha Cognition Inc. | -9.7 Million USD | -3121.923% |
| HST Global, Inc. | -5303.00 USD | -5896694.267% |
| CSL Limited | 4.78 Billion USD | 106.53% |
| Halberd Corporation | -74.27 Thousand USD | -420889.782% |
| Enzolytics Inc. | -2.12 Million USD | -14636.227% |
| Resverlogix Corp. | -11.74 Million USD | -2563.149% |
| Affymax, Inc. | -14.29 Million USD | -2087.527% |
| SYBLEU INC | -141.57 Thousand USD | -220783.514% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | -10109.121% |
| argenx SE | -216.02 Million USD | -44.756% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | -465.075% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | 25794.906% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | -20762.349% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | 82642.419% |
| AVAX Technologies, Inc. | -6.11 Million USD | -5015.741% |
| Zenith Capital Corp. | -8.6 Million USD | -3533.593% |
| Genscript Biotech Corporation | -248.71 Million USD | -25.727% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -1794900.287% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | -12682.015% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | -177549.843% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | -688.93% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | -10711.61% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.04 Million USD | -29786.592% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | 4650709.756% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.74 Million USD | -17768.982% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | -16179.099% |
| BioStem Technologies, Inc. | -7.55 Million USD | -4039.816% |
| ONE Bio Corp. | 13.61 Million USD | 2397.113% |
| Reve Technologies, Inc. | -181.08 Thousand USD | -172582.342% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | -2.05 Million USD | -15102.09% |
| Agentix Corp. | -1.37 Million USD | -22696.11% |
| LadRx Corporation | 412.28 Thousand USD | 75947.658% |
| Cell Source, Inc. | -4.27 Million USD | -7219.019% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | -85054.988% |
| Regen BioPharma, Inc. | 1.46 Million USD | 21431.268% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | -33275.029% |
| NovAccess Global Inc. | -1.03 Million USD | -30119.164% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | 3631.896% |
| Itoco Inc. | -1.86 Million USD | -16631.291% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | -82273.689% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -27920.341% |
| Kadimastem Ltd | -2.62 Million USD | -11815.457% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | -130657.683% |
| CytoDyn Inc. | -18.02 Million USD | -1634.467% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | -395586.394% |
| Mobile Lads Corp. | -2.24 Million USD | -13852.915% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | -2556993.793% |
| Qrons Inc. | -40.08 Thousand USD | -780087.62% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | -64285.663% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | 59388.478% |
| Rebus Holdings, Inc. | -951 Thousand USD | -32781.914% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | -29344.826% |
| International Stem Cell Corporation | 202 Thousand USD | 154905.446% |
| Bioxytran, Inc. | -3.82 Million USD | -8085.732% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -593948.252% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | -12601.691% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -35.86 Million USD | -771.803% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -45 Thousand USD | -694804.444% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | -11321.001% |
| Neutra Corp. | -181.24 Thousand USD | -172430.856% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -1451.203% |
| PureTech Health plc | -11.62 Million USD | -2589.49% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | -1451.309% |
| IXICO plc | -707 Thousand USD | -44130.127% |
| IntelGenx Technologies Corp. | -7.68 Million USD | -3969.057% |
| Gelesis Holdings, Inc. | -48.34 Million USD | -546.81% |
| CSL Limited | 4.73 Billion USD | 106.607% |
| Cellectis S.A. | -92.63 Million USD | -237.565% |